Next Article in Journal
Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
Next Article in Special Issue
Formulation and Evaluation of Polymeric Spherical Agglomerates-Based Porous Orodispersible Tablets of Cilnidipine
Previous Article in Journal
Molecular Docking and Antihypertensive Activity of Eupalitin 3-O-β-D-galactopyranoside Isolated from Boerhavia diffusa Linn
Previous Article in Special Issue
Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(12), 1630; https://doi.org/10.3390/pharmaceutics16121630
Action Date Notes Link
article xml file uploaded 23 December 2024 10:19 CET Original file -
article xml uploaded. 23 December 2024 10:19 CET Update https://www.mdpi.com/1999-4923/16/12/1630/xml
article pdf uploaded. 23 December 2024 10:19 CET Version of Record https://www.mdpi.com/1999-4923/16/12/1630/pdf
article html file updated 23 December 2024 10:21 CET Original file https://www.mdpi.com/1999-4923/16/12/1630/html
Back to TopTop